Number of Hematologic Complications of Immune Checkpoint Inhibitors Appears to Be Increasing
Hemolytic anemia and immune thrombocytopenic purpura were the most common complications of immune checkpoint inhibitor therapy.
Sonali Gattani
Editor https://www.clinicaladvisor.com
Sonali Gattani is the editor for Hematology Advisor and part of the Medical Communications Group of Haymarket Media. She holds a BA in philosophy-neuroscience-psychology from Washington University in St. Louis, where she served as editor-in-chief of the Washington University Academic Starter Guide.
